1
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer. 75:203–210. 1995. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
neoadjuvant cooperative osteosarcoma study group protocols. J Clin
Oncol. 20:776–790. 2002. View Article : Google Scholar
|
3
|
Culver KW, Anderson WF and Blaese RM:
Lymphocyte gene therapy. Hum Gene Ther. 2:107–109. 1991. View Article : Google Scholar
|
4
|
Abdelrahim M, Safe S, Baker C and
Abudayyeh A: RNAi and cancer: implications and applications. J RNAi
Gene Silencing. 2:136–145. 2006.PubMed/NCBI
|
5
|
Rubinson DA, Dillon CP, Kwiatkowski AV, et
al: A lentivirus-based system to functionally silence genes in
primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Manilla P, Rebello T, Afable C, et al:
Regulatory considerations for novel gene therapy products: a review
of the process leading to the first clinical lentiviral vector. Hum
Gene Ther. 16:17–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Dutertre S, Descamps S and Prigent C: On
the role of aurora-A in centrosome function. Oncogene.
21:6175–6183. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tong T, Zhong Y, Kong J, et al:
Overexpression of Aurora-A contributes to malignant development of
human esophageal squamous cell carcinoma. Clin Cancer Res.
10:7304–7310. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tanaka E, Hashimoto Y, Ito T, et al: The
clinical significance of Aurora-A/STK15/BTAK expression in human
esophageal squamous cell carcinoma. Clin Cancer Res. 11:1827–1834.
2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li D, Zhu J, Firozi PF, et al:
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human
pancreatic cancer. Clin Cancer Res. 9:991–997. 2003.PubMed/NCBI
|
11
|
Gritsko TM, Coppola D, Paciga JE, et al:
Activation and overexpression of centrosome kinase BTAK/Aurora-A in
human ovarian cancer. Clin Cancer Res. 9:1420–1426. 2003.PubMed/NCBI
|
12
|
Miyoshi Y, Iwao K, Egawa C and Noguchi S:
Association of centrosomal kinase STK15/BTAK mRNA expression with
chromosomal instability in human breast cancers. Int J Cancer.
92:370–373. 2001. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Sen S, Zhou H, Zhang RD, et al:
Amplification/overexpression of a mitotic kinase gene in human
bladder cancer. J Natl Cancer Inst. 94:1320–1329. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bacci G, Ferrari S, Mercuri M, et al:
Neoadjuvant chemotherapy for osteosarcoma of the extremities in
patients aged 41–60 years: outcome in 34 cases treated with
adriamycin, cisplatinum and ifosfamide between 1984 and 1999. Acta
Orthop. 78:377–384. 2007.
|
15
|
Murdoch D and Sager J: Will targeted
therapy hold its promise? an evidence-based review. Curr Opin
Oncol. 20:104–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li CX, Parker A, Menocal E, Xiang S,
Borodyansky L and Fruehauf JH: Delivery of RNA interference. Cell
Cycle. 5:2103–2109. 2006. View Article : Google Scholar
|
17
|
Dave RS and Pomerantz RJ: RNA
interference: on the road to an alternate therapeutic strategy! Rev
Med Virol. 13:373–385. 2003.PubMed/NCBI
|
18
|
Marumoto T, Zhang D and Saya H: Aurora-A -
a guardian of poles. Nat Rev Cancer. 5:42–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ke YW, Dou Z, Zhang J and Yao XB: Function
and regulation of Aurora/Ipl1p kinase family in cell division. Cell
Res. 13:69–81. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Katayama H, Sasai K, Kawai H, et al:
Phosphorylation by Aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|